RKTO logo

RKTO
Rocket One Inc.

12,422
Mkt Cap
$26.01M
Volume
68.67M
52W High
$2.12
52W Low
$0.4894
PE Ratio
-1.68
RKTO Fundamentals
Price
$1.70
Prev Close
$1.36
Open
$2.02
50D MA
$0.733
Beta
1.11
Avg. Volume
6.85M
EPS (Annual)
-$0.9032
P/B
5.32
Rev/Employee
$0.00
$7.43
Loading...
Loading...

About

Hoth Therapeutics, Inc. engages in the development of new generation therapies for dermatological disorders. Its product pipeline focuses on potential treatments for indications including atopic dermatitis (also known as eczema), chronic wounds, psoriasis, asthma, and acne. It offers the BioLexa Platform, a drug compound platform for the treatment of eczema. The company was founded by Robbie Knie, Matthew D. Eitner, and James Ahern on May 16, 2017 and is headquartered in New York, NY.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
6

Frequently Asked Questions

What is Market Cap of Rocket One Inc.?
What is the 52-week high for Rocket One Inc.?
What is the 52-week low for Rocket One Inc.?
What is Rocket One Inc. stock price today?
What was Rocket One Inc. stock price yesterday?
What is the PE ratio of Rocket One Inc.?
What is the Price-to-Book ratio of Rocket One Inc.?
What is the 50-day moving average of Rocket One Inc.?
How many employees does Rocket One Inc. have?

Compact View

Mini-Chart
Sentiment
Not available
Message Volume
Not available